Indication: Epilepsy and Autism
Safety and Tolerability of GWP42006 in Subjects with Drug Resistant Epilepsy and Autism—Extension Safety Study
Sub-indication: Epilepsy and Autism
Study Type: Drug Study
Principal Investigator: Gregory Barnes, M.D.Norton Children's Autism Center, affiliated with the UofL School of Medicine
Sponsor: Sponsor: GW Pharmaceuticals
